Development of longitudinal studies to overcome global Hispanic/Latino underrepresentation in clinical research: a need for collaborative efforts

The Lancet Regional Health - Americas 2026 Open access

Read full text
Authors: Alexandro J. Martagón, Gabriela Livas, Guillermo Torre‐Amione, Pablo Kuri-Morales
DOI: 10.1016/j.lana.2026.101392
Cited by: 0
References: 6

Abstract

The Latino population comprises a significant share of the global population, with more than 662 million Latinos in Latin America and the Caribbean and another 61 million in the United States.1 Despite comprising such a large portion of the health-seeking population, Latinos are significantly underrepresented in clinical research, magnifying existing health disparities. According to the NIH, in the US, Latinos make up only 6% of participants in clinical trials, while only around 3.4% of oncology clinical trials are conducted in this region.

Fields of Study & Subjects

Ethics in Clinical Research Race Genetics and Society Latin American and Latino Studies

Publication details

Journal / source
The Lancet Regional Health - Americas
Volume
56
Pages
101392–101392
Publication date
10 February 2026
Language
EN